| Taizhou Crene Biotechnology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (576) 8881-3233 8820-5808 +86 13396860566 | |||
![]() |
order@pharm-intermediates.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink standard supplier since 2009 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Classification | API >> Antineoplastic agents |
|---|---|
| Name | Riviciclib |
| Synonyms | 2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methyl-3-pyrrolidinyl]-4H-1-benzopyran-4-one |
| Molecular Structure | ![]() |
| Molecular Formula | C21H20ClNO5 |
| Molecular Weight | 401.84 |
| CAS Registry Number | 920113-02-6 |
| Solubility | Very slightly soluble (0.11 g/L) (25 ºC), Calc.* |
|---|---|
| Density | 1.429±0.06 g/cm3 (20 ºC 760 Torr), Calc.* |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs) |
| Market Analysis Reports |
| List of Reports Available for Riviciclib |